A Study to Evaluate the Effects of ACI-7104.056 in Patients With Early Stages of Parkinson's Disease
Trial details
- Registry ID
- NCT06015841
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Study to Evaluate the Effects of ACI-7104.056 in Patients With Early Stages of Parkinson's DiseaseNCT06015841 | ACIU | Phase 2 | Active not recruiting | 2028-06Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |